PMID: 8033045Jul 15, 1994Paper

Long term survival by cytoreductive surgery to less than 1 cm, induction weekly cisplatin and monthly cisplatin, doxorubicin, and cyclophosphamide therapy in advanced ovarian adenocarcinoma

Cancer
T R BakerR E Hempling

Abstract

Survival rates for patients with advanced epithelial ovarian cancer remain low despite improved chemotherapy regimens and cytoreductive surgery. One hundred thirty-six patients with Stage III or IV ovarian cancer were treated with primary cytoreductive surgery followed by cisplatin induction, 1 mg/kg weekly x 4 followed by 10 cycles of cisplatin (50 mg/m2), doxorubicin (50 mg/m2), and cyclophosphamide (750 mg/m2). Second-look surgery was performed on those patients who were clinically without evidence of disease at the end of the planned chemotherapy course. Survival and progression-free survival were calculated, and prognostic factors regarding survival and progression-free survival were evaluated by both univariate and multivariate analyses. Cytoreductive surgery to less than or equal to 2 cm was performed on 83% of patients and to less than 1 cm in 40%. A surgical complete response (SCR) rate of 34.9% and surgical partial response (SPR) rate of 47.6% were noted. Of the SCRs, recurrences developed in 52.7% of the patients. Estimated 5- and 8-year survival for all 136 patients was 31.2% and 21.5%, and 5- and 8-year progression-free survival was 23.9% and 20.6%, respectively. Those patients with less than 1-cm residual disease ...Continue Reading

References

Feb 1, 1978·The Surgical Clinics of North America·C T Griffiths, A F Fuller
Dec 1, 1979·American Journal of Obstetrics and Gynecology·J P Smith, T G Day
Oct 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P J HoskinsJ L Benedet
Jan 1, 1992·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A de GramontS Delfau
Jan 1, 1991·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J P NeijtM van Lent
Mar 1, 1991·Gynecologic Oncology·M E PotterH M Shingleton
Feb 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G P SuttonC E Ehrlich
Nov 1, 1986·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K G LouieR C Young
Jun 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M S PiverL J Emrich
Jun 1, 1986·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P F ConteL Santi
Sep 1, 1987·American Journal of Obstetrics and Gynecology·D G GallupK W Brown
Nov 1, 1985·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C J WilliamsJ H Shepherd
Jan 1, 1986·Gynecologic Oncology·J M CainJ L Lewis
May 15, 1985·American Journal of Obstetrics and Gynecology·K C PodratzT A Gaffey
Apr 1, 1984·American Journal of Obstetrics and Gynecology·J T WhartonF N Rutledge
Dec 1, 1984·Cancer·M S Piver

❮ Previous
Next ❯

Citations

Sep 1, 1996·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·T SugiyamaH Nishimura
Dec 1, 1995·European Journal of Obstetrics, Gynecology, and Reproductive Biology·M BrinkhuisJ P Baak
Dec 10, 1999·Critical Reviews in Oncology/hematology·P F ConteA Gadducci
Mar 10, 2001·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·M. SuzukiI. Sato
Feb 7, 2004·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·A AyhanK Yüce
Feb 7, 2004·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·M LookP H Sugarbaker
Dec 17, 2003·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·M LookP H Sugarbaker
Mar 7, 2006·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·T PaulsenC Tropé
Feb 16, 2007·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·H H ChungUNKNOWN Gynecologic Oncology Committee of Korean Society of Obstetrics and Gynecology
Sep 2, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Laura J HavrileskyUNKNOWN Gynecologic Oncology Group
Aug 1, 2006·Gynecologic Oncology·Scott M EisenkopWei-Chien Michael Lin
Jun 28, 2005·Surgical Oncology Clinics of North America·Sarah H Hughes, Michael A Steller
Oct 7, 2006·Gynecologic Oncology·Giovanni D AlettiWilliam A Cliby
Mar 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert E BristowF J Montz
Aug 13, 2011·The Cochrane Database of Systematic Reviews·Ahmed ElattarRaj Naik

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics
E EkiciO Gökmen
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
R Y ZangQ Liu
© 2021 Meta ULC. All rights reserved